The Panakeia Strain: Why CBG Is the New CBD

What Is the Panakeia Strain?

The Panakeia strain is a hemp or cannabis cultivar associated with high cannabigerol (CBG) levels and minimal THC. Breeders designed this strain to produce more cannabigerol. It gives both growers and consumers exactly what they want and skips the intoxicating high that higher-THC cannabis usually causes. 

That is a big reason Panakeia is getting attention. Most people associate hemp with CBD, while cannabis conversations tend to focus on THC. Panakeia stands out because it shifts attention to CBG, a cannabinoid usually found in much lower amounts in cannabis plants. 

People know Panakeia as a THC-free cannabis strain. Health Europa reports that Hemp Trading and the Universidad Politécnica de Valencia developed this strain together. Additionally, they claim it boasts up to 18% CBG and no THC. 

However, you should treat these numbers carefully. Always verify the results with a current certificate of analysis (COA) and ensure it confirms the exact batch you want to buy. 

What Is CBG?

CBG stands for cannabigerol, one of many cannabinoids found in the cannabis plant. Like CBD, CBG is generally considered non-intoxicating. That means it is not usually associated with the “high” most people connect with THC. But CBG and CBD are not the same compound, and they do not have identical research or effects.

CBG is often found in smaller amounts than THC or CBD because the plant uses its earlier form during development. That is why high-CBG hemp varieties like Panakeia matter. They make CBG easier to grow, study, and formulate into oils, gummies, flower, and other products.

Why Is CBG Called the Mother Cannabinoid

CBG’s acidic form, CBGA, acts as the starting ingredient for several major cannabinoids. That’s why people often call CBG the “mother cannabinoid.”

A 2022 pharmacology review explains exactly how this works. As the plant grows, CBGA transforms into compounds such as THC, CBD, and CBC. Picture CBGA as raw dough. The plant’s enzymes then step in to decide exactly what final product they will bake.

That is exactly why Panakeia is so interesting. Its genetics preserve more of that cannabigerol. The plant avoids turning it all into THC or CBD.

CBG vs CBD: How Are They Similar and Different?

The CBG vs CBD comparison matters because many readers already know CBD but are new to CBG.

Here are the main similarities:

• Plant Source: Derived from hemp or cannabis plants.
• Non-Intoxicating: Generally considered to have no psychoactive effects.
• Product Variety: Available in various forms, including oils, gummies, topicals, capsules, and flower.
• Ongoing Research: Currently being studied for a range of potential wellness and medical applications.

Here are the main differences:

• CBD has far more human research than CBG.
• CBG is newer in the consumer market and has less clinical evidence.
• CBD has one FDA-approved prescription drug, Epidiolex, for certain seizure disorders.
• Over-the-counter CBD and CBG products are not the same thing as FDA-approved medicines.

The FDA approved Epidiolex for the treatment of specific seizures. This medication contains purified cannabidiol. Doctors prescribe it for Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.

Many people say CBG feels more “clear” or “daytime friendly” compared to CBD. But keep in mind that medical experts haven’t proven this, and not everyone experiences those same effects.

Why CBG Isn’t Necessarily “Better CBD”

Calling CBG “the new CBD” is a market phrase, not a medical verdict.

CBG might feel a bit different for some users. People looking for a narrower cannabinoid profile might enjoy Panakeia products. However, that doesn’t make CBG better than CBD. It won’t work for every symptom, and you should never use it to replace your prescription medications.

CBD has a stronger research base and broader public understanding. CBG is promising, but still early. The safer takeaway is that CBG is different, not superior.

What Research Says About CBG

We should stay balanced when discussing CBG research. Scientists are curious about it. However, most of the evidence still comes from early lab tests.

A major 2024 review calls CBG a non-psychoactive cannabinoid. The researchers highlight its many potential health benefits, for example, neuroprotection, pain management, and cancer treatment. while also stressing the need for stronger human data.

That matters for everyone, from everyday readers to patients. It is perfectly fine to be curious about CBG products. But don’t assume a product works simply because it is generating a lot of hype online.

Early Human Research on Stress and Mood

A 2024 clinical trial is one of the main reasons why CBG is getting so much attention. During the study, 34 healthy adults took 20 mg of hemp-derived CBG. Researchers found that this lowered their anxiety and stress levels compared to a placebo. Best of all, the CBG didn’t cause an intoxicating high. It also didn’t mess with anyone’s thinking or coordination.

That said, the study has limits:

• The sample included only a small number of participants.
• The participants were healthy adults rather than patients diagnosed with anxiety disorders.
• Researchers focused only on short-term, acute dosing.
• The findings do not show that CBG broadly treats anxiety or stress-related conditions.

Overall, the trial is encouraging, but it is not sufficient to support broad treatment claims.

Preclinical Research on Inflammation, Skin, Pain, and Gut Health

Researchers are also testing CBG in lab and animal models. They want to see how it affects inflammation, skin health, pain, appetite, eye pressure, and gut function.

The 2022 pharmacology review that was mentioned earlier also explains how CBG interacts with our bodies. It binds to cannabinoid receptors and targets several biological pathways. However, scientists still need to confirm these early findings with real human trials.

Early lab tests help guide future research. But they don’t prove a cannabinoid will cure patients in the real world. You might see product pages making huge promises. They might claim their CBG fixes pain, skin diseases, or stomach issues. When you see this, slow down. Always check whether there is actual human evidence to back up those bold claims.

Why Is CBG Called the New CBD?

CBD helped make hemp products mainstream in the United States. Now, consumers want to learn about more targeted cannabinoid profiles, and that is helping fuel interest in CBG.

Panakeia matters in that trend because it makes growing, extracting, and formulating CBG much easier. A plant that reliably produces high CBG and very low THC changes the game. It helps companies source cleaner ingredients and create products that are much more consistent.

So why is CBG being called the new CBD?

• Consumers are looking beyond CBD.
• Brands want newer cannabinoid options.
• Growers want genetics with more specific cannabinoid profiles.
• Early research and anecdotal interest are driving curiosity. 

It is a useful phrase for trend-watching, but not a scientific ranking.

What Panakeia Could Mean for the Hemp Market

If strains like Panakeia become more popular, the hemp market could get much more precise. Buyers won’t ask if a product contains CBD anymore. They will want to know exactly how much CBG it packs. They will ask if the THC is low. They will also double-check how recent the lab tests are.

This shift is good news for patients and everyday consumers alike. Better plant genetics produce more consistent extracts. They create cleaner labels and make safety testing much easier. Plus, this helps stop companies from selling products with vague or misleading claims.

How to Shop for Panakeia or CBG Products Safely

Product quality varies a lot, especially outside licensed dispensaries. Shopping carefully matters whether you are buying CBG flower, gummies, tinctures, or vapes.

Start with a few practical questions:

• Is there a recent third-party COA?
• Does the label clearly list the amount of CBG per serving?
• Does it show total THC or just delta-9 THC?
• Is the batch number listed?
• Are there contaminant tests for heavy metals, pesticides, mold, and solvents?

If these basics are missing, move on.

Check the Certificate of Analysis Before Buying

The COA is one of the most important documents a buyer can review. It helps you verify what is actually in the product.

Check for:

• The amount of CBG
• Total THC and delta-9 THC
• Contaminants
• Batch number
• Test date
• Lab identity

If a label says “THC-free,” the lab results should back that up. That matters not just for peace of mind but also for legal compliance and drug-testing risk.

Understand Full-Spectrum, Broad-Spectrum, and Isolate

These terms matter when shopping for CBG or CBD products:

• Full-spectrum means the product contains multiple cannabinoids and may include trace THC.
• Broad-spectrum usually means multiple cannabinoids are present, but THC has been removed or reduced to very low levels.
• Isolate means that a single cannabinoid has been separated, such as pure CBG.

These categories can affect how a product feels and whether it creates a drug-test risk. The NCCIH warns that over-the-counter CBD products may contain more or less cannabinoid than labeled and may contain contaminants such as THC. The same caution applies to CBG products.

Know Your State’s Rules

U.S. hemp and cannabis rules do not work the same way in every state. Hemp-derived cannabinoids may be federally lawful when compliant with the 2018 Farm Bill definition of hemp, which is cannabis containing no more than 0.3% delta-9 THC on a dry-weight basis. But state restrictions can still vary for flower, vapes, edibles, and intoxicating or semi-synthetic cannabinoids.

Federal hemp rules are also changing. You should monitor official sources for updates on total THC limits and other regulatory changes that may affect hemp-derived cannabinoid products in the coming years.

Check your state’s medical marijuana laws and learn whether you may qualify for a medical card.

Is CBG Right for Medical Cannabis Patients?

CBG may be worth discussing if you are curious about non-intoxicating cannabinoids, especially if THC feels too strong for you or if you want to learn more about broader cannabis options. But “worth discussing” is not the same thing as “right for everyone.”

Patients should be cautious if they:

• Take prescription medications
• Are pregnant or breastfeeding
• Have liver concerns
• Have heart conditions
• Have a history of psychosis
• Are managing complex chronic symptoms without clinician guidance

When to Talk to a Medical Marijuana Doctor

It makes sense to seek a medical cannabis evaluation when:

• You are using cannabinoids for symptoms, not just casual wellness
• You already take medications and want to avoid interactions
• You are unsure whether hemp products are enough for your needs
• You want to know if you may qualify for a state medical program
• You need help understanding THC, CBD, CBG, ratios, and product formats

Ready to explore medical cannabis with professional guidance? Talk to a certified cannabis doctor today.

Conclusion

Interest in Panakeia and other high-CBG strains reflects growing curiosity about non-intoxicating cannabinoids that may offer different effects compared to CBD and THC. However, CBG research remains limited, and there is no clear clinical consensus on how to use it for specific health concerns.

Because of this uncertainty, medical cannabis guidance becomes relevant for individuals who are considering CBG for symptom management rather than general wellness. A medical marijuana doctor can help assess whether cannabinoid-based options are appropriate based on a person’s symptoms, current medications, and overall health needs, as well as the safety and legal considerations of high-CBG products. 

For those who decide to explore this path, Quick Med Cards provides access to licensed professionals who can offer this type of evaluation in accordance with state regulations.

Key Takeaways

• The Panakeia strain is best known as a high-CBG, very low-THC hemp variety.
• CBG is generally non-intoxicating, but it is not the same compound as CBD.
• “The new CBD” is a trend phrase, not proof that CBG is medically better.
• Early CBG research is promising, including a small 2024 human study, but the evidence base is still limited.
• Lab testing matters, especially if a product claims to be THC-free.
• In the United States, legality depends on both federal hemp rules and your state’s laws.

Frequently Asked Questions

Below are answers to common questions about CBG and the Panakeia strain.

Disclaimer: This article is for educational purposes only and does not replace medical or legal advice. Cannabis and hemp laws change, and cannabinoid products may affect people differently. Always review current lab results, check your state’s rules, and speak with a licensed healthcare professional before using cannabinoid products for health-related reasons.